ArticleTranslational andrology and urology2023
The safety and effectiveness of laparoscopic anterior sacral ligament suspension combined with dome suspension in the treatment of bladder prolapse after hysterectomy: a retrospective cohort study.
Article in Translational andrology and urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Laparoscopic anterior sacral ligament suspension combined with dome suspension (L-ASLS + DS) and transperineal whole pelvic floor reconstruction (T-WPFR) are 2 methods for treating bladder prolapse after hysterectomy. In clinical practice, we found that L-ASLS + DS has better safety and effectiveness than T-WPFR, but there is no relevant study comparing the safety and effectiveness of these two methods. We sought to compare the efficacy and safety of L-ASLS + DS and T-WPFR in treating hysterectomy-induced bladder prolapse overa 1-year follow-up period. Methods: A total 146 patients with bladder prolapse after hysterectomy who attended Shanxi Provincial People's Hospital from January 2011 to January 2022 were included in this study. Patients were divided into study group and control group by voluntary means or economic reasons. In total, 75 patients received L-ASLS + DS surgery and 71 patients received T-WPFR surgery to treat hysterectomy-induced bladder prolapse. The L-ASLS + DS-treated patients comprised the study group, while the T-WPFR-treated patients comprised the control group. The perioperative indicators, curative effect, and postoperative complication rates in the follow-up period were compared between the 2 groups. Results: L-ASLS + DS outperformed T-WPFR in terms of the perioperative indicators, and the incidence of postoperative complications in the L-ASLS + DS group was significantly lower than that in the T-WPFR group. Conclusions: L-ASLS + DS can be used to effectively treat bladder prolapse after hysterectomy. L-ASLS + DS reduced the incidence of postoperative complications, improved the cure rate, and was shown to be safe. Thus, it is worthy of comprehensive clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.